Cargando…
A case report on the effect of rituximab on pyothorax-associated lymphoma
RATIONALE: Pyothorax-associated lymphoma (PAL) is a rare type of malignant pleural lymphoma. Most lymphomas are normally discovered around 20 to 50 years after tuberculosis infection. In China, there have been few reports about PAL cases so far. We report a case of a patient, whose tuberculosis and...
Autores principales: | Wang, Fei, Lan, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922375/ https://www.ncbi.nlm.nih.gov/pubmed/31852157 http://dx.doi.org/10.1097/MD.0000000000018393 |
Ejemplares similares
-
T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report
por: Shao, Yajuan, et al.
Publicado: (2018) -
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report
por: Cerchione, Claudio, et al.
Publicado: (2020) -
Pyothorax-associated lymphoma (PAL): report and review of a rare entity
por: Welcker, Katrin, et al.
Publicado: (2004) -
Arcanobacterium haemolyticum associated with pyothorax: case report
por: Parija, Subhash Chandra, et al.
Publicado: (2005) -
Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma
por: Chen, Guang-Liang, et al.
Publicado: (2021)